65678e0f212eaade2e0eb3ea
|
2019
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2019014735b
|
03ZZ0820B
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.131387
|
0
|
0
|
0
|
0.131387
|
0
|
0
|
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
INNOVATION FUNDING IN THE NEW ...LÄNDER
more
|
Innovation funding in the new ...Länder
more
|
Molecular serology for the rap...id determination of antibody titers against infectious diseases that can be prevented by publicly recommended vaccinations in capillary blood samples of immigrants and other patient cohorts - Medical research of particular importance for developing countries
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
61009
|
Other non-financial corporatio...ns
more
|
Other non-financial corporatio...ns
more
|
|
|
65678e0f212eaade2e0eb3eb
|
2019
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2019014735c
|
03ZZ0820C
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.0210272
|
0
|
0
|
0
|
0.0210272
|
0
|
0
|
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
INNOVATION FUNDING IN THE NEW ...LÄNDER
more
|
Innovation funding in the new ...Länder
more
|
Molecular serology for rapid d...etermination of vaccination titres against vaccine-preventable infectious diseases (STIKO list) in migrants and other groups of patients. - Medical research of particular importance for developing countries
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
61009
|
Other non-financial corporatio...ns
more
|
Other non-financial corporatio...ns
more
|
|
|
65678e0f212eaade2e0eb3ec
|
2019
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2019014735d
|
03ZZ0820D
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.0744581
|
0
|
0
|
0
|
0.0744581
|
0
|
0
|
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
INNOVATION FUNDING IN THE NEW ...LÄNDER
more
|
Innovation funding in the new ...Länder
more
|
Molecular serology for rapid d...etermination of vaccination titres against vaccine-preventable infectious diseases (STIKO list) in migrants and other groups of patients - Medical research of particular importance for developing countries
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Higher education institution
|
|
|
65678e10212eaade2e0eb3ed
|
2019
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2019014280
|
01DQ17003
|
3
|
India
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
1.53E-5
|
0.0461794
|
0
|
0
|
1.53E-5
|
0.0461794
|
0
|
0
|
|
1.53E-5
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
SCIENTIFIC COOPERATION WITH OT...HER COUNTRIES (NOT INCLUDED IN OTHER AREAS)
more
|
Scientific cooperation with ot...her countries (not included in other areas)
more
|
Improving the clinical care of... children and young adults with Marfan Syndrome and related disorders by molecular genetic testing through next-generation sequencing - Medical research of particular importance for developing countries
more
|
|
12382
|
Research for prevention and co...ntrol of NCDs
more
|
|
I.2.c. Non-communicable diseas...es (NCDs)
more
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Higher education institution
|
|
|
65678e10212eaade2e0eb3ee
|
2019
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2019014283
|
01DQ17008
|
3
|
India
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.0428555
|
0
|
0
|
0
|
0.0428555
|
0
|
0
|
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
SCIENTIFIC COOPERATION WITH OT...HER COUNTRIES (NOT INCLUDED IN OTHER AREAS)
more
|
Scientific cooperation with ot...her countries (not included in other areas)
more
|
Noncontact Assessment of Vital... Parameters of Neonates in Intensive care - Medical research of particular importance for developing countries
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Higher education institution
|
|
|
65678e10212eaade2e0eb3ef
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020013960B
|
01QE1833B
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.050472
|
0
|
0
|
0
|
0.050472
|
|
0
|
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
MISCELLANEOUS IN THE AREA OF I...NTERNATIONAL UNDERSTANDING
more
|
Miscellaneous in the area of i...nternational understanding
more
|
Collaborative project - Establ...ishing radical innovation in the development of vaccines, sub-project - Development of a dengue disease map as a semantic model for the integration of vaccination assay data and machine learning-based data analysis - Medical research of particular importance for developing countries - infectious disease abatement
more
|
0
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
61009
|
Other non-financial corporatio...ns
more
|
Other non-financial corporatio...ns
more
|
|
|
65678e10212eaade2e0eb3f0
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020013960C
|
01QE1833C
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.101839
|
0
|
0
|
0
|
0.101839
|
|
0
|
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
MISCELLANEOUS IN THE AREA OF I...NTERNATIONAL UNDERSTANDING
more
|
Miscellaneous in the area of i...nternational understanding
more
|
Collaborative project - Establ...ishing radical innovation in the development of vaccines, sub-project - Development of dengue virus reporter particles for measuring the immunogenicity of new vaccine candidates in a humanized mouse model - Medical research of particular importance for developing countries - infectious disease abatement
more
|
0
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Higher education institution
|
|
|
65678e10212eaade2e0eb3f1
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020013961
|
01QE1916
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.097896
|
0
|
0
|
0
|
0.097896
|
|
0
|
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
MISCELLANEOUS IN THE AREA OF I...NTERNATIONAL UNDERSTANDING
more
|
Miscellaneous in the area of i...nternational understanding
more
|
Collaborative project - Develo...pment and testing of a hot-weather vaccine refrigerator powered by solar water heating, Sub-project - aDLA - self-sufficient double-lift adsorption cooling - development of an adsorption chiller for hot regions and implementation of field tests - Energy technologies and energy efficiency
more
|
0
|
23210
|
Energy generation, renewable s...ources - multiple technologies
more
|
|
II.3.b. Energy generation, ren...ewable sources
more
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Teaching institution/Research ...and development institute
more
|
|
|
65678e10212eaade2e0eb3f2
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020014161B
|
03ZZ0820B
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.009621
|
0
|
0
|
0
|
0.009621
|
|
0
|
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
INNOVATION FUNDING IN THE NEW ...LÄNDER
more
|
Innovation funding in the new ...Länder
more
|
Molecular serology for the rap...id determination of antibody titers against infectious diseases that can be prevented by publicly recommended vaccinations in capillary blood samples of immigrants and other patient cohorts - Medical research of particular importance for developing countries
more
|
0
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
61009
|
Other non-financial corporatio...ns
more
|
Other non-financial corporatio...ns
more
|
|
|
65678e10212eaade2e0eb3f3
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020013724
|
01DQ17003
|
3
|
India
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.000324
|
0
|
0
|
0
|
0.000324
|
|
0
|
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
SCIENTIFIC COOPERATION WITH OT...HER COUNTRIES (NOT INCLUDED IN OTHER AREAS)
more
|
Scientific cooperation with ot...her countries (not included in other areas)
more
|
Improving the clinical care of... children and young adults with Marfan Syndrome and related disorders by molecular genetic testing through next-generation sequencing - Medical research of particular importance for developing countries
more
|
0
|
12382
|
Research for prevention and co...ntrol of NCDs
more
|
|
I.2.c. Non-communicable diseas...es (NCDs)
more
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Higher education institution
|
|
|
65678e11212eaade2e0eb3f4
|
2016
|
Sweden
|
The Swedish Research Council
|
2014006318
|
2013-6727
|
3
|
Burkina Faso
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.025244
|
0
|
0
|
0
|
0.025244
|
0
|
0
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
TOOLS TO STUDY THE EFFECTS OF ...ROTAVIRUS VACCINATION IN BURKINA FASO
more
|
Tools to study the effects of ...rotavirus vaccination in Burkina Faso
more
|
Diarrhea is a major global hea...lth issue in children, and heavily affects sub-Saharan Africa. Rotavirus is the major cause for severe childhood diarrhea, thus rotavirus vaccines are an important preventive measure of diarrhea. Vaccine trials have, however, showed a reduced vaccine efficacy in many African countries. Burkina Faso is now about to implement vaccination nationwide and our research proposal is centered on this. By closely monitoring rotavirus before; during and after national immunization, we can investigate factors important for vaccine efficacy. A first objective is to establish RV surveillance logistics and techniques before vaccination. We have performed preliminary studies and found many unusual strains which could influence vaccine efficacy. The major objective is to determine the vaccine efficacy and relate this to evolving escape mutants and specific strains present in Burkina Faso. Our third scientific approach is most novel and based on preliminary data from Burkina Faso observing that children with the Lewis-negative phenotype, common in Burkina Faso, where not infected with vaccine-like strains, providing an explanation for reduced vaccine efficacy in Africa. The overall objective of this collaboration is increased knowledge and better techniques to study RV and factors important for successful vaccination; which will be done through regular workshops, lectures and scientific visits by researchers from Sweden and Burkina Faso.
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Linköpings universitet
|
|
|
65678e11212eaade2e0eb3f5
|
2014
|
Sweden
|
Sida
|
2014063533
|
SE-0-SE-6-5410005401-GGG-12182
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
5.02923
|
0
|
0
|
0
|
5.02923
|
0
|
0
|
5.02923
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
INTERNATIONAL VACCINE INSTITUT...E 2015-2019 - INTERNATIONAL VACCINE INSTITUTE 2014-2018
more
|
International Vaccine Institut...e 2015-2019 - International Vaccine Institute 2014-2018
more
|
International Vaccine Institut...e is a research institute producing vaccines in order to reduce the burden of diarrheal and respiratoral diseases in low-income countries. Sida's core support is used for laboratory based research, technical assistance to vaccine producers and regulators in the developing world, and to help reinforce an international network of collaborating research institutions.
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
21000
|
International NGOs
|
INTERNATIONAL NGO
|
|
|
65678e11212eaade2e0eb3f6
|
2014
|
Sweden
|
Sida
|
2014061190
|
SE-0-SE-6-5410007301-GGG-12182
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.0145775
|
0.0101905
|
0
|
0
|
0.0145775
|
0.0101905
|
0
|
0.0145775
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
AGREEMENT ON REPRESENTATION BY... SE, IVI BOARD - AGREEMENT FOR BOT REPRESENTATION FOR IVI 2014
more
|
Agreement on representation by... SE, IVI board - Agreement for BoT representation for IVI 2014
more
|
International Vaccine Institut...e is an NGO aiming at making vaccines available in LICs in order to reduce the burden of childhood diseases and thus <5 mortality. Sweden has since 2006 a representative in IVI's Board of Trustees and the Swedish Ministry of Foreign Affairs has given Sida the administrative responsibility to handle this.
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
12000
|
Recipient government
|
Recipient Government
|
|
|
65678e11212eaade2e0eb3f7
|
2017
|
Sweden
|
The Swedish Research Council
|
2014293410
|
2014-4329
|
3
|
Uganda
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.028665
|
0
|
0
|
0
|
0.028665
|
0
|
0
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
IMPLEMENTING UNINTERRUPTED SKI...N-TO-SKIN CONTACT BETWEEN MOTHERS AND NEWBORNS IMMEDIATELY AFTER BIRTH IN UGANDA
more
|
IMPLEMENTING UNINTERRUPTED SKI...N-TO-SKIN CONTACT BETWEEN MOTHERS AND NEWBORNS IMMEDIATELY AFTER BIRTH IN UGANDA
more
|
In Uganda 2% of mothers have u...ninterrupted skin-to-skin contacts (SSC) with their infant after birth, 83% of infants have hypothermia which is one of the leading causes of mortality in newborns and the rate of exclusively breastfeeding at 1 month is 57%. SSC has positive effects on infant temperature and initiating of breastfeeding. We will study if a simple low-cost intervention that can enhance early initiation and duration of breastfeeding can be implemented. The medical staff and the hospital management will be shown a DVD containing information about newborns' instinctive behavior and the benefits of SSC and this information will also be spread in pamphlets and posters. A quasi-experimental design will be used with data collections before and after the intervention. 60 mother-infant pairs will be included in each of the 2 data collections. SSC and breastfeeding will be observed and the temperature of the infant will be measured. 1 month after birth the mothers will be interviewed about breastfeeding and interpretation of their infant's cues. Focus group interviews will be performed with the staff to investigate what they perceive as facilitating factors and barriers to implement SSC. If proven effective the intervention can be implemented in other low resource settings. This is a joint research collaboration originating from a Linneaus-Palme supported student and teacher exchange between the midwifery programmes at Karolinska Institutet and Makerere University.
more
|
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Karolinska Institutet
|
|
|
65678e12212eaade2e0eb3f8
|
2015
|
Sweden
|
Sida
|
2015900387
|
SE-0-SE-6-5403025201-GGG-15160
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0
|
0.00395638
|
0
|
0
|
0
|
0.00791276
|
0
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
50
|
OXFAM GB (+NOVIB) 2011-2014 - ...OXFAM GB (+NOVIB) BARN 2011-2014
more
|
OXFAM GB (+NOVIB) 2011-2014 - ...OXFAM GB (+NOVIB) BARN 2011-2014
more
|
The 'My Rights, My Voice: Enga...ging marginalised children and youth in their rights to health and education services' programme is a three-year multi-country programme which will deliver a holistic and contextualised vision of children's and youth's rights to health and education in eight countries – Niger, Mali, Afghanistan, Tanzania, Georgia, Nepal, Pakistan, and Vietnam.
more
|
|
15160
|
Human rights
|
|
I.5.a. Government & Civil Soci...ety-general
more
|
21000
|
International NGOs
|
INTERNATIONAL NGO
|
|
|
65678e12212eaade2e0eb3f9
|
2015
|
Sweden
|
Sida
|
2015060889
|
SE-0-SE-6-5410005401-GGG-12182
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
4.09287
|
0.711803
|
0
|
0
|
4.09287
|
0.711803
|
0
|
4.09287
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
INTERNATIONAL VACCINE INSTITUT...E 2015-2019 - INTERNATIONAL VACCINE INSTITUTE 2014-2018
more
|
INTERNATIONAL VACCINE INSTITUT...E 2015-2019 - INTERNATIONAL VACCINE INSTITUTE 2014-2018
more
|
International Vaccine Institut...e is a research institute producing vaccines in order to reduce the burden of diarrheal and respiratoral diseases in low-income countries. Sida's core support is used for laboratory based research, technical assistance to vaccine producers and regulators in the developing world, and to help reinforce an international network of collaborating research institutions.
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
21000
|
International NGOs
|
INTERNATIONAL NGO
|
|
|
65678e12212eaade2e0eb3fa
|
2017
|
Sweden
|
Swedish International Developm...ent Authority
more
|
2015061132
|
SE-0-SE-6-5410016901-GGG-12182
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.00584731
|
0
|
0
|
0
|
0.00584731
|
0
|
0
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
AGREEMENT ON SERVICES, UKÄ, 2...015 - 2017
more
|
Agreement on Services, UKÄ, 2...015 - 2017
more
|
International Vaccine Institut...e, IVI aims at making vaccines available in LICs in order to reduce the burden of childhood diseases and thus <5 mortality. Sweden has since 2006 a representative in IVI's Board of Trustees and the Swedish Ministry of Foreign Affairs has given Sida the administrative responsibility to handle this.
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
11001
|
Central Government
|
UNIVERSITETSKANSLERSÄMBETET
|
|
|
65678e12212eaade2e0eb3fb
|
2018
|
Sweden
|
The Swedish Research Council
|
20160290046
|
2015-03206_2
|
3
|
Bangladesh
|
South & Central Asia
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.0416168
|
0
|
0
|
0
|
0.0416168
|
0
|
0
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
RICE, MALNUTRITION AND MULTIPL...E METALS – REASONS FOR IMPAIRED CHILD GROWTH AND DEVELOPMENT?
more
|
Rice, malnutrition and multipl...e metals – reasons for impaired child growth and development?
more
|
Against the background of the ...recent reports of alarming concentrations of toxic metals like arsenic and cadmium in rice-based baby food, the overall aim of this application is to assess the influence of early-life exposure to rice-based metals on children's growth and cognitive and behavioral development. Also high concentrations of manganese, an essential element which is shown to be neurotoxic at higher doses, have been detected in infant food. Specifically, we will i) estimate the exposure to the toxic metals through rice; ii) evaluate different biomarkers of manganese exposure; iii) evaluate associations of exposure biomarkers (in children with low arsenic and manganese in drinking water) with available data on child growth and development, including effects of combined exposure; and iv) assess the interactions with known susceptibility factors, such as nutrition, gender, and genetic predisposition. The studies will be based on our ongoing large and well-characterized mother-child cohort (n=1500) in a poor area in rural Bangladesh. Because rice is the main staple food and the nutritional status varies markedly, this cohort provides unique possibilities to evaluate potential health effects of the toxic metals in rice on children and important susceptibility factors. In this cohort, we have assessed child anthropometry and development (cognitive performance and behavior) at 1.5, 5 and 10 years of age in relation to elevated metals exposure through drinking water. The total exposure to arsenic, cadmium and manganese is based on available concentrations in biomarkers, such as concentrations in urine and blood, measured in the mothers during pregnancy and in the children at the different follow-ups. We also have detailed information on the concentrations in the drinking water used over time. In a sub-sample, we have also measured metals and other trace elements in rice (various types and degree of polishing). The exposure to the metals through rice will be evaluated based on the i) estimated intake through rice, ii) the biomarker concentrations in the children with low concentrations in the drinking water and iii) the intercept of the biomarker concentrations regressed against the drinking water concentrations. As there is no known biomarker for manganese exposure, we will, in a sub-sample evaluate the relationship between various biomarkers (urine, blood, plasma, and hair), analyzed by modern ICP-MS in clean-room facilities, and also with the concentrations in water. All biomarker concentrations will also be compared with those in rice, measured in a sub-sample of the cohort. Evaluations will be gender-specific and consider nutritional status (anthropometry, SES and biomarker concentrations of selenium, zinc, and iodine), known to affect both absorption and toxicity. We will also evaluate impact of polymorphisms in genes related to kinetics of arsenic (main arsenic methyltransferase, AS3MT) and manganese (the solute carrier SLC30A10, coding
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Karolinska Institutet
|
|
|
65678e13212eaade2e0eb3fc
|
2018
|
Sweden
|
The Swedish Research Council
|
20160290045
|
2015-03206_1
|
3
|
Cambodia
|
Far East Asia
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.0416168
|
0
|
0
|
0
|
0.0416168
|
0
|
0
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
RICE, MALNUTRITION AND MULTIPL...E METALS – REASONS FOR IMPAIRED CHILD GROWTH AND DEVELOPMENT?
more
|
Rice, malnutrition and multipl...e metals – reasons for impaired child growth and development?
more
|
Against the background of the ...recent reports of alarming concentrations of toxic metals like arsenic and cadmium in rice-based baby food, the overall aim of this application is to assess the influence of early-life exposure to rice-based metals on children's growth and cognitive and behavioral development. Also high concentrations of manganese, an essential element which is shown to be neurotoxic at higher doses, have been detected in infant food. Specifically, we will i) estimate the exposure to the toxic metals through rice; ii) evaluate different biomarkers of manganese exposure; iii) evaluate associations of exposure biomarkers (in children with low arsenic and manganese in drinking water) with available data on child growth and development, including effects of combined exposure; and iv) assess the interactions with known susceptibility factors, such as nutrition, gender, and genetic predisposition. The studies will be based on our ongoing large and well-characterized mother-child cohort (n=1500) in a poor area in rural Bangladesh. Because rice is the main staple food and the nutritional status varies markedly, this cohort provides unique possibilities to evaluate potential health effects of the toxic metals in rice on children and important susceptibility factors. In this cohort, we have assessed child anthropometry and development (cognitive performance and behavior) at 1.5, 5 and 10 years of age in relation to elevated metals exposure through drinking water. The total exposure to arsenic, cadmium and manganese is based on available concentrations in biomarkers, such as concentrations in urine and blood, measured in the mothers during pregnancy and in the children at the different follow-ups. We also have detailed information on the concentrations in the drinking water used over time. In a sub-sample, we have also measured metals and other trace elements in rice (various types and degree of polishing). The exposure to the metals through rice will be evaluated based on the i) estimated intake through rice, ii) the biomarker concentrations in the children with low concentrations in the drinking water and iii) the intercept of the biomarker concentrations regressed against the drinking water concentrations. As there is no known biomarker for manganese exposure, we will, in a sub-sample evaluate the relationship between various biomarkers (urine, blood, plasma, and hair), analyzed by modern ICP-MS in clean-room facilities, and also with the concentrations in water. All biomarker concentrations will also be compared with those in rice, measured in a sub-sample of the cohort. Evaluations will be gender-specific and consider nutritional status (anthropometry, SES and biomarker concentrations of selenium, zinc, and iodine), known to affect both absorption and toxicity. We will also evaluate impact of polymorphisms in genes related to kinetics of arsenic (main arsenic methyltransferase, AS3MT) and manganese (the solute carrier SLC30A10, coding
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Karolinska Institutet
|
|
|
65678e13212eaade2e0eb3fd
|
2018
|
Sweden
|
The Swedish Research Council
|
20160290047
|
2015-03206_3
|
3
|
Democratic People's Republic o...f Korea
more
|
Far East Asia
|
Other LICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.0416168
|
0
|
0
|
0
|
0.0416168
|
0
|
0
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
RICE, MALNUTRITION AND MULTIPL...E METALS – REASONS FOR IMPAIRED CHILD GROWTH AND DEVELOPMENT?
more
|
Rice, malnutrition and multipl...e metals – reasons for impaired child growth and development?
more
|
Against the background of the ...recent reports of alarming concentrations of toxic metals like arsenic and cadmium in rice-based baby food, the overall aim of this application is to assess the influence of early-life exposure to rice-based metals on children's growth and cognitive and behavioral development. Also high concentrations of manganese, an essential element which is shown to be neurotoxic at higher doses, have been detected in infant food. Specifically, we will i) estimate the exposure to the toxic metals through rice; ii) evaluate different biomarkers of manganese exposure; iii) evaluate associations of exposure biomarkers (in children with low arsenic and manganese in drinking water) with available data on child growth and development, including effects of combined exposure; and iv) assess the interactions with known susceptibility factors, such as nutrition, gender, and genetic predisposition. The studies will be based on our ongoing large and well-characterized mother-child cohort (n=1500) in a poor area in rural Bangladesh. Because rice is the main staple food and the nutritional status varies markedly, this cohort provides unique possibilities to evaluate potential health effects of the toxic metals in rice on children and important susceptibility factors. In this cohort, we have assessed child anthropometry and development (cognitive performance and behavior) at 1.5, 5 and 10 years of age in relation to elevated metals exposure through drinking water. The total exposure to arsenic, cadmium and manganese is based on available concentrations in biomarkers, such as concentrations in urine and blood, measured in the mothers during pregnancy and in the children at the different follow-ups. We also have detailed information on the concentrations in the drinking water used over time. In a sub-sample, we have also measured metals and other trace elements in rice (various types and degree of polishing). The exposure to the metals through rice will be evaluated based on the i) estimated intake through rice, ii) the biomarker concentrations in the children with low concentrations in the drinking water and iii) the intercept of the biomarker concentrations regressed against the drinking water concentrations. As there is no known biomarker for manganese exposure, we will, in a sub-sample evaluate the relationship between various biomarkers (urine, blood, plasma, and hair), analyzed by modern ICP-MS in clean-room facilities, and also with the concentrations in water. All biomarker concentrations will also be compared with those in rice, measured in a sub-sample of the cohort. Evaluations will be gender-specific and consider nutritional status (anthropometry, SES and biomarker concentrations of selenium, zinc, and iodine), known to affect both absorption and toxicity. We will also evaluate impact of polymorphisms in genes related to kinetics of arsenic (main arsenic methyltransferase, AS3MT) and manganese (the solute carrier SLC30A10, coding
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Karolinska Institutet
|
|
|
65678e13212eaade2e0eb3fe
|
2016
|
Sweden
|
Swedish International Developm...ent Authority
more
|
2015068243
|
SE-0-SE-6-5410005401-GGG-12182
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
0
|
0.759656
|
0
|
0
|
0
|
0.759656
|
0
|
0
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
INTERNATIONAL VACCINE INSTITUT...E 2015-2019
more
|
International Vaccine Institut...e 2015-2019
more
|
International Vaccine Institut...e, established in 1997 is a multilateral research institute, which develops vaccines in order to reduce the burden of diarrheal and respiratoral diseases in low-income countries. IVI offers technical assistance to vaccine producers and regulators in the developing world, and mantain an international network of collaborating research institutions.
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
21000
|
International NGOs
|
International NGO
|
|
|
65678e14212eaade2e0eb3ff
|
2017
|
Sweden
|
Swedish International Developm...ent Authority
more
|
2017060121A
|
SE-0-SE-6-5410014701-GGG-12182
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.0531309
|
0.053131
|
0
|
0
|
0.0531309
|
0.053131
|
0
|
0.0531309
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
SUSTAINABILITY STUDY OF IVI 20...17
more
|
Sustainability study of IVI 20...17
more
|
The contribution is for a stud...y on the sustainability of International Vaccine Institute's, (IVI's) research results as well as the uptake up vaccines produced by the institute.
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
KIT, HEALTH & EDUCATION / ROYA...L TROPICAL INSTITUTE
more
|
|
|
65678e14212eaade2e0eb400
|
2019
|
Sweden
|
The Swedish Research Council
|
20170290033
|
2016-05670
|
3
|
Kenya
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.0412441
|
0
|
0
|
0
|
0.0412441
|
0
|
0
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
CAPACITY-BUILDING THROUGH A CL...USTER RANDOMIZED TRIAL -- A PRE- AND POST-TEST INTERVENTION TO PREVENT ABORTION AND CONTRACEPTIVE-USE STIGMA AMONG HEALT
more
|
Capacity-building through a Cl...uster Randomized Trial -- A Pre- and Post-Test Intervention to Prevent Abortion and Contraceptive-use Stigma among Healt
more
|
This collaborative capacity-bu...ilding project is an extension of a VR-funded project ending 2016. New collaborators are University of Nairobi and International Pregnancy Advisory Services (Ipas). Unsafe abortion is a leading cause of maternal mortality (MM) and morbidity in Kenya. Social stigma surrounding abortion and contraceptive use plays a critical role in social, medical, and legal marginalization of abortion- and contraceptive service. In 2013, Ipas developed the Stigmatizing Attitudes, Beliefs and Actions Scale (SABAS) to measure abortion stigma at individual and community level. Objective: I) to conceptualize abortion stigma among health care providers in youth friendly centres, teachers and students in secondary school (14-18 y) in a sub-urban area with high MM, and II) to determine if a school based abortion- and contraceptive-stigma reduction intervention will decrease stigma, and increase contraceptive use among students. Design, Setting, Participants: I) focus group discussions with providers, teachers and students, and II) a quantitative quasi-experimental intervention study involving 800 students from schools in western Kenya that will be cluster-randomised into intervention and control units. Main Outcome: abortion-stigma. Secondary outcome: contraceptive use. Outcome measured by using the validated SABA-scale before and after intervention and comparing intervention and control schools. Analyses: Qualitative content analysis and repeated measures ANOVA (PASW).
more
|
|
12182
|
Medical research
|
3.b
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Karolinska Institutet
|
|
|
65678e14212eaade2e0eb401
|
2019
|
Sweden
|
The Swedish Research Council
|
20170290041
|
2016-05696
|
3
|
Malawi
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.0412441
|
0
|
0
|
0
|
0.0412441
|
0
|
0
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
HYPOGLYCAEMIA IN PAEDIATRIC IN...FECTIONS IN SUB SAHARAN AFRICA - EXPLORING RISKS, REASONS AND TREATMENT NEEDS
more
|
Hypoglycaemia in paediatric in...fections in sub Saharan Africa - exploring risks, reasons and treatment needs
more
|
Mortality from severe infectio...ns in young children remains high in sub-Saharan African hospitals where the role of supportive therapies, such as maintaining normal glucose and electrolyte balances, has been given limited attention. Although hyperglycemia is commonly seen in patients with infectious diseases in high-income settings, hypoglycemia is not uncommon in low-income settings. The current definition of hypoglycemia is a blood glucose of less than 2.5mmol/l: this is found in 7.3% of children admitted with fever, with an associated mortality rate of 42%. An increased mortality has also been reported in acutely ill children with low-normal blood glucose levels of 2.5 - 5.0mmol/l. The causes of the low levels of blood glucose and the reasons for increased mortality rates are not known. This collaboration between the pediatric department at University of Malawi and Karolinska Insitutet's Health System and Policy group will link two recognized research institutions to study the causes and treatment of glucose abnormalities in pediatric infections.A randomized clinical trial will start in early 2016 to evaluate the benefits of glucose administration in children admitted with severe infections and low-normal blood glucose levels. The trial may lead to a revision of the current definition of hypoglycemia. The two main applicants will act as joint principal investigators and junior researchers from both sites will be involved to ensure the formation of a long-term collaboration.
more
|
|
12182
|
Medical research
|
3.b
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Karolinska Institutet
|
|
|
65678e15212eaade2e0eb402
|
2020
|
Sweden
|
The Swedish Research Council
|
2018290054
|
2017-05579
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.130297
|
0
|
0
|
|
0.130297
|
0
|
0
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
HYPOGLYCAEMIA IN PAEDIATRIC IN...FECTIONS IN SUB-SAHARAN AFRICA - PREVALENCE, PREDICTORS AND POTENTIAL PREVENTION
more
|
Hypoglycaemia in paediatric in...fections in sub-Saharan Africa - prevalence, predictors and potential prevention
more
|
Mortality from pneumonia, mala...ria and other infections in young children remains high in sub-Saharan African. Since the majority of children first see a primary health worker when sick, recent global health initiatives have focused on strengthening community health programs to provide early access to antimalarial and antimicrobial drugs. However, the role of supportive therapies, involving the maintenance of a normal glucose and electrolyte balance, has been given limited attention. Hypoglycaemia is a known predictor of poor outcome with a case fatality rate of as much as 42%. In sub-Saharan African hospitals up to 7.3% of children admitted with fever present with hypoglycaemia. The majority of these children have been referred from lower level facilities and development of hypoglycaemia could potentially have been averted if stabilising treatment had been started already at the health centre. We will do a baseline study in two districts in Malawi to assess the prevalence of paediatric dysglycemia among children with severe illness in primary health facilities and the risk of post-referral hypoglycaemia. Results will feed into a cluster-randomized trial to evaluate the impact of administrating pre-referral sublingual glucose and continuous oral rehydration solution on the incidence of post-referral hypoglycaemia. Our results will highlight the potential need to revise pre-referral management guidelines in order to increase child survival in acute illness.
more
|
0
|
12182
|
Medical research
|
3.b
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Karolinska Institutet
|
|
|
65678e15212eaade2e0eb403
|
2020
|
Sweden
|
The Swedish Research Council
|
2018290028
|
2017-05474
|
3
|
Uganda
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.162872
|
0
|
0
|
|
0.162872
|
0
|
0
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
DEVELOPMENTAL DISABILITIES IN ...UGANDA: EARLY DETECTION AND INTERVENTION
more
|
Developmental disabilities in ...Uganda: Early detection and intervention
more
|
Developmental delay and disabi...lity (DDD) affect more than 100 million children worldwide, the majority living in low income settings and often failing to receive even basic education or health care. Recent findings in developmental neuroscience highlight the importance of an enriched, supportive and healthy environment in the first years of life for achieving one's developmental potential, with children with DDD at high risk for poor outcomes. This project aims to make these children visible and to examine the extent to which they are excluded from participation in family and community activities, and to implement and evaluate intervention strategies addressing their unmet health and developmental needs. We will expand our collaborative studies with a Health and Demographic Surveillance System in Uganda by first exploring the epidemiology of all types of DDD in children ages 1-9 years using a three-stage screening process. Next, we will train a team of community and health workers for a controlled early intervention study on these children in collaboration with UNICEF. In addition, we will perform a 3-year longitudinal follow up of our previously identified cohort of children with cerebral palsy and design, execute and evaluate goal directed interventions. Critical knowledge gaps in global outcomes for children with DDD will be addressed through this project and successful interventions will be scaled up and disseminated to other nations by the UNICEF collaboration.
more
|
0
|
12182
|
Medical research
|
3.b
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Karolinska Institutet
|
|
|
65678e15212eaade2e0eb404
|
2020
|
Sweden
|
The Swedish Research Council
|
2018290908
|
2018-03609
|
3
|
Cambodia
|
Far East Asia
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.043161
|
0
|
0
|
|
0.043161
|
0
|
0
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
CREATING CAPACITY TO EXAMINE T...HE LINKS BETWEEN SUSTAINABLE DEVELOPMENT GOALS AND THEIR EFFECT ON GLOBAL CHILD HEALTH.
more
|
Creating capacity to examine t...he links between Sustainable Development Goals and their effect on global child health.
more
|
The Sustainable Development Go...als (SDGs) and the 2030 Agenda have redefined the international development cooperation work globally. Since the goals are interconnected, they must be tackled in an integrated way. Hence, the SDGs offer new opportunities for sectors to collaborate to achieve sustainable progress on common issues. The purpose of this collaboration is to develop a common research project regarding the SDGs and child health between institutions in Sweden, Cambodia and Southeast Asia. Specifically, the project would lead to synthesized evidence of the impact of the non-health sector on child health globally and in the collaborative countries as well as an identification, description and classification of the linkages between child health and the SDGs both globally, regionally and on a country level. The collaboration and research project will be developed during a two year period, with project activities including study visit to Cambodia, a small pilot study in Cambodia, regional meetings in Bangkok and an international workshop in Sweden. This collaboration will be the first ever attempt at creating an empirical base for assessing SDG interactions in a health policy area. A better understanding of the linkages between SDGs can form a basis for bridging science and decision making and provide a lever to push governments to take multisectoral action not only in child health but in other areas as well, enabling transformative action both at national and global level.
more
|
0
|
12182
|
Medical research
|
3.b
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Karolinska Institutet
|
|
|
65678e16212eaade2e0eb405
|
2020
|
Sweden
|
Swedish International Developm...ent Authority
more
|
2019060848A
|
SE-0-SE-6-12892A0101-GGG-91010
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
G01
|
0
|
0.005773
|
0
|
0
|
|
0.005773
|
0
|
|
|
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
SWEDISH REPRESENTATION ON BOAR...D OF IVI 2019-2021
more
|
Swedish representation on Boar...d of IVI 2019-2021
more
|
Sida/Sweden nominates and fina...nces a representative of the International Vaccine Institute (IVI) Board of Trustees. The financing covers travel and salary costs for the representative of Sweden at the Board meetings (2 physical meetings and four-five phone meeting per year). IVI has a mandate in the development of vaccins to poverty related diseases. The Swedish nominee needs thorough knowledge in drug discovery and development from both academia and industry, as well as knowledge of Sweden's priorities and research cooperation in international development cooperation.
more
|
0
|
91010
|
Administrative costs (non-sect...or allocable)
more
|
3.b
|
Administrative Costs of Donors
|
11001
|
Central Government
|
Sida
|
|
|
65678e17212eaade2e0eb406
|
2020
|
Sweden
|
The Swedish Research Council
|
2020290798A
|
2020-04737
|
1
|
Nigeria
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.070578
|
0
|
0
|
0
|
0.070578
|
0
|
0
|
0
|
0
|
0.070578
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
PREVENTING PAEDIATRIC PNEUMONI...A DEATHS IN NIGERIA
more
|
Preventing paediatric pneumoni...a deaths in Nigeria
more
|
Oxygen has recently become one... of the most valuable global commodities as a result of the COVID-19 pandemic, exposing gaps in current service provision. Therefore, large investments in both pulse oximetry and oxygen systems have been promised by international donors for low-respurce settings. With 800,000 annual paediatric pneumonia deaths, working in equitable partnerships to ensure that the rapid investment and scale-up is context-appropriate and sustainable is therefore crucial to secure the potential of future benefits of newly installed oxygen systems for child survival.The aim of the VR Networks Links Grant is to promote long term and sustainable health system strengthening in the area of paediatric pneumonia in Nigeria through mutual capacity building beween University College Hospital Ibadan and Karolinska Institutet. We will do this through joint supervision of a Nigerian PhD student in clinical community paediatric pneumonia research, dissemination workshops using the Every Breath Counts Coalition platform, strategic planning for wider scale-up and sustainability, jointly publishing academic papers.The network will focus around the primary research question: What is the impact of pulse oximetry at primary and secondary health facilities and improved oxygen at secondary health facilities on case-fatality rates (CFR) for clinical pneumonia cases in children under-5 in Lagos state, Nigeria?
more
|
|
12182
|
Medical research
|
3.b
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Karolinska Institutet
|
|
|
65678e17212eaade2e0eb407
|
2014
|
United Kingdom
|
BIS
|
2011800985
|
MC_U123292700
|
8
|
Gambia
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.851893
|
0.851893
|
0
|
0
|
0.851893
|
0.851893
|
0
|
0.851893
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
NUTRITIONAL GENETICS AND ENVIR...ONMENTAL FACTORS IN DISEASE
more
|
Nutritional Genetics and Envir...onmental Factors in Disease
more
|
Nutritional Genetics and Envir...onmental Factors in Disease
more
|
|
12240
|
Basic nutrition
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Developing country-based NGO
|
|
|
65678e17212eaade2e0eb408
|
2014
|
United Kingdom
|
BIS
|
2011800986
|
MC_U123292701
|
8
|
Gambia
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
1.13586
|
1.13586
|
0
|
0
|
1.13586
|
1.13586
|
0
|
1.13586
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
NUTRITIONAL MODULATION OF IMMU...NITY AND INFECTIOUS DISEASES
more
|
Nutritional Modulation of Immu...nity and infectious Diseases
more
|
Nutritional Modulation of Immu...nity and infectious Diseases
more
|
|
12240
|
Basic nutrition
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Developing country-based NGO
|
|
|
65678e18212eaade2e0eb409
|
2014
|
Asian Development Fund
|
AsDF
|
2014002484
|
LN1228-SAM
|
3
|
Samoa
|
Oceania
|
LMICs
|
ODA Loans
|
4
|
10
|
410
|
C01
|
0
|
0
|
0.0911407
|
0
|
0
|
0
|
0.0911407
|
0
|
0
|
0
|
Classified as not health-speci...fic activity
more
|
|
100
|
AFULILO HYDROELECTRIC PROJECT-...SUPPL.
more
|
Afulilo Hydroelectric Project-...Suppl.
more
|
Afulilo Hydroelectric Project-...Suppl.
more
|
|
99810
|
Sectors not specified
|
|
IX. Unallocated / Unspecified
|
12000
|
Recipient government
|
|
|
|
65678e18212eaade2e0eb40a
|
2017
|
United Kingdom
|
Department for International D...evelopment
more
|
2012000824
|
203115-101
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0
|
0.0222964
|
0
|
0
|
0
|
0.0222964
|
0
|
|
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
IFPRI STUDY ON AFLATOXIN AND C...HILD STUNTING LINKS
more
|
IFPRI study on aflatoxin and c...hild stunting links
more
|
The purpose of this reserach i...s to extend the evidence base on the association between dietary exposure to aflatoxin (highly posionous moulds found in maize and other crops) and child growth. The research uses a randomised controlled trial methodology to
more
|
|
31182
|
Agricultural research
|
|
III.1.a. Agriculture
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
University, college or other t...eaching institution, research institute or think?tank
more
|
|
|
65678e18212eaade2e0eb40b
|
2015
|
UNFPA
|
UNFPA
|
2015004342
|
|
3
|
Mozambique
|
South of Sahara
|
LDCs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0
|
0.00324818
|
0
|
0
|
|
0.00324818
|
|
|
|
|
Classified as not health-speci...fic activity
more
|
|
100
|
ANALYSIS ON POPULATION DYNAMIC...S
more
|
Output 13: Analysis on populat...ion dynamics
more
|
Mozambique - Maputo. Output 13...: Increased availability of evidence through cutting-edge in-depth analysis on population dynamics, sexual and reproductive health, HIV and their linkages to poverty eradication and sustainable development
more
|
Analysis on population dynami...cs
more
|
16062
|
Statistical capacity building
|
|
I.6. Other Social Infrastructu...re & Services
more
|
12000
|
Recipient government
|
Governments
|
|
|
65678e19212eaade2e0eb40c
|
2015
|
UNFPA
|
UNFPA
|
2015004219
|
|
3
|
Mongolia
|
Far East Asia
|
LMICs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0
|
0.0219888
|
0
|
0
|
|
0.0219888
|
|
|
|
|
Classified as not health-speci...fic activity
more
|
|
100
|
DATA ON POPULATION AND DEVELOP...MENT
more
|
Output 12: Data on Population ...and Development
more
|
Mongolia -Ulaan Baatar. Output... 12: Strengthened national capacity for production and dissemination of quality disaggregated data on population and development issues that allows for mapping of demographic disparities and socio-economic inequalities, and for programming in humanitarian settings
more
|
Data on Population and Develop...ment
more
|
13010
|
Population policy and administ...rative management
more
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
|
|
UNFPA
|
|
|
65678e19212eaade2e0eb40d
|
2015
|
UNICEF
|
UNICEF
|
2015002439
|
2880/A0/04/300/307
|
8
|
Mongolia
|
Far East Asia
|
LMICs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.0286025
|
0.0286025
|
0
|
0
|
0.0286025
|
0.0286025
|
0
|
10
|
1
|
12
|
Classified as not health-speci...fic activity
more
|
|
100
|
EARLY CHILDHOOD EDUCATION
|
EARLY CHILDHOOD EDUCATION
|
EARLY CHILDHOOD EDUCATION
|
|
11110
|
Education policy and administr...ative management
more
|
|
I.1.a. Education, Level Unspec...ified
more
|
|
|
|
|
|
65678e1a212eaade2e0eb40e
|
2016
|
United Kingdom
|
Department for Business, Innov...ation and Skills
more
|
2016004537
|
RB_MRC_AA_MR/J014362/1
|
8
|
Africa, regional
|
Africa
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.0696241
|
0.0696241
|
0
|
0
|
0.0696241
|
0.0696241
|
0
|
0.0696241
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
DEVELOPMENT OF A STATISTICAL M...ODELLING FRAMEWORK TO INFORM REAL-TIME IMMUNIZATION STRATEGIES FOR ELIMINATION OF POLIOMYELITIS AND OTHER DISEASES
more
|
Development of a statistical m...odelling framework to inform real-time immunization strategies for elimination of poliomyelitis and other diseases
more
|
Medical Research Council. Fell...owship to develop models to predict outcomes of differing immunisation strategies against polio
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
University, college or other t...eaching institution, research institute or think?tank
more
|
|
|
65678e1a212eaade2e0eb40f
|
2016
|
United Kingdom
|
Department for Business, Innov...ation and Skills
more
|
2016004511
|
RB_MRC_BR_MR/K01188X/1
|
8
|
Brazil
|
South America
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.0220612
|
0.0220612
|
0
|
0
|
0.0220612
|
0.0220612
|
0
|
0.0220612
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
MRC/FAPESP - BILATERAL AGREEME...NT: MULTIPLE-EPITOPE VACCINE TO CONFER SEROTYPE-INDEPENDENT PROTECTION AGAINST PNEUMONIA
more
|
MRC/FAPESP - bilateral agreeme...nt: Multiple-epitope vaccine to confer serotype-independent protection against pneumonia
more
|
Medical Research Council. Rese...arch Grant to develop potential new vaccines against pneumonia
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
University, college or other t...eaching institution, research institute or think?tank
more
|
|
|
65678e1a212eaade2e0eb410
|
2016
|
United Kingdom
|
Department for Business, Innov...ation and Skills
more
|
2016004508
|
RB_MRC_CN_MR/M022161/1
|
8
|
China (People's Republic of)
|
Far East Asia
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.00508852
|
0.00508852
|
0
|
0
|
0.00508852
|
0.00508852
|
0
|
0.00508852
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
DEVELOP AN INTERVENTIONAL STUD...Y ON REDUCING ANTIBIOTIC OVER-PRESCRIBING AMONG CHILDREN WITH URIS IN RURAL GUANGXI, CHINA
more
|
Develop an interventional stud...y on reducing antibiotic over-prescribing among children with URIs in rural Guangxi, China
more
|
Medical Research Council Joint... (MRC/WT/DfID) Global Health Trial development grant aiming to reduce antibiotic over-prescribing among children with URIs in rural Guangxi, China
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
University, college or other t...eaching institution, research institute or think?tank
more
|
|
|
65678e1a212eaade2e0eb411
|
2016
|
United Kingdom
|
Department for Business, Innov...ation and Skills
more
|
2016004490
|
RB_MRC_IN_MR/K007270/1
|
8
|
India
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.0209525
|
0.0209525
|
0
|
0
|
0.0209525
|
0.0209525
|
0
|
0.0209525
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
COMMUNITY INTERVENTION TO IMPR...OVE GROWTH AMONG CHILDREN UNDER 2 IN RURAL INDIA
more
|
Community intervention to impr...ove growth among children under 2 in rural India
more
|
Medical Research Council. Rese...arch Grant to test a community intervention to improve child growth and development
more
|
|
12261
|
Health education
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
University, college or other t...eaching institution, research institute or think?tank
more
|
|
|
65678e1a212eaade2e0eb412
|
2016
|
United Kingdom
|
Department for Business, Innov...ation and Skills
more
|
2016004487
|
RB_MRC_IN_MR/M005186/1
|
8
|
India
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.175277
|
0.175277
|
0
|
0
|
0.175277
|
0.175277
|
0
|
0.175277
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
FETAL PROGRAMMING OF HEALTH AN...D DISEASE; FOLLOW-UP OF CHILDREN WHOSE MOTHERS TOOK PART IN A PRE-CONCEPTIONAL NUTRITION TRIAL IN MUMBAI, INDIA
more
|
Fetal programming of health an...d disease; follow-up of children whose mothers took part in a pre-conceptional nutrition trial in Mumbai, India
more
|
Medical Research Council. Rese...arch Grant to investigate the longer term outcomes of children whose mothers participated in a nutritional supplementation trial
more
|
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
University, college or other t...eaching institution, research institute or think?tank
more
|
|
|
65678e1b212eaade2e0eb413
|
2016
|
United Kingdom
|
Department for Business, Innov...ation and Skills
more
|
2016004485
|
RB_MRC_IN_MR/M021904/1
|
8
|
India
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.0040388
|
0.0040388
|
0
|
0
|
0.0040388
|
0.0040388
|
0
|
0.0040388
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
A FEASIBILITY AND PILOT STUDY ...OF THE EFFECTS OF ROJIROTI MICROFINANCE ON THE HEALTH AND NUTRITION OF CHILDREN UNDER FIVE IN BIHAR, NORTHERN INDIA
more
|
A feasibility and pilot study ...of the effects of Rojiroti microfinance on the health and nutrition of children under five in Bihar, northern India
more
|
Medical Research Council Joint... (MRC/WT/DfID) Global Health Trial development grant to look at potential microfinance schemes for mothers and the health and nutrition of young children in northern India
more
|
|
12191
|
Medical services
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
University, college or other t...eaching institution, research institute or think?tank
more
|
|
|
65678e1b212eaade2e0eb414
|
2016
|
United Kingdom
|
Department for Business, Innov...ation and Skills
more
|
2016004474
|
RB_MRC_KE_MR/M007367/1
|
8
|
Kenya
|
South of Sahara
|
Other LICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.052476
|
0.052476
|
0
|
0
|
0.052476
|
0.052476
|
0
|
0.052476
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
FIRST LINE ANTIMICROBIALS IN C...OMPLICATED SEVERE ACUTE MALNUTRITION (FLACSAM)
more
|
First Line Antimicrobials in C...omplicated Severe Acute Malnutrition (FLACSAM)
more
|
Medical Research Council Joint... (MRC/WT/DfID) Global Health Trial grant to assess the optimal antibiotic treatment of children with severe acute malnutrition (SAM)
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
University, college or other t...eaching institution, research institute or think?tank
more
|
|
|
65678e1b212eaade2e0eb415
|
2016
|
United Kingdom
|
Department for Business, Innov...ation and Skills
more
|
2016004459
|
RB_MRC_MW_MR/M022390/1
|
8
|
Malawi
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.00551248
|
0.00551248
|
0
|
0
|
0.00551248
|
0.00551248
|
0
|
0.00551248
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
EXPLORATORY OBSERVATIONAL STUD...Y OF THERAPEUTIC FEEDS USED TO TREAT INTESTINAL INFLAMMATION IN MALAWIAN CHILDREN WITH SEVERE ACUTE MALNUTRITION (SAM)
more
|
Exploratory observational stud...y of therapeutic feeds used to treat intestinal inflammation in Malawian children with severe acute malnutrition (SAM)
more
|
Medical Research Council Joint... (MRC/WT/DfID) Global Health Trial development grant to test therapeutic feeds in Malawian children with severe acute malnutrition
more
|
|
12240
|
Basic nutrition
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
University, college or other t...eaching institution, research institute or think?tank
more
|
|
|
65678e1b212eaade2e0eb416
|
2016
|
United Kingdom
|
Department for Business, Innov...ation and Skills
more
|
2016004367
|
RB_MRC_TZ_MR/K021672/1
|
8
|
Tanzania
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.0626534
|
0.0626534
|
0.0313267
|
0
|
0.0626534
|
0.0626534
|
0.0313267
|
0.0626534
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
POPULATION HEALTH MEETS EVOLUT...IONARY ANTHROPOLOGY: FAMILY STRUCTURE, RURAL LIVELIHOODS AND CHILD HEALTH IN TANZANIA
more
|
POPULATION HEALTH MEETS EVOLUT...IONARY ANTHROPOLOGY: FAMILY STRUCTURE, RURAL LIVELIHOODS AND CHILD HEALTH IN TANZANIA
more
|
Medical Research Council. Fell...owship to undertake research to improve current understandings of the impact of family structure on child wellbeing in the developing world
more
|
|
13010
|
Population policy and administ...rative management
more
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
University, college or other t...eaching institution, research institute or think?tank
more
|
|
|
65678e1b212eaade2e0eb417
|
2016
|
United Kingdom
|
Department for Business, Innov...ation and Skills
more
|
2016004347
|
RB_MRC_UG_MR/N003810/1
|
8
|
Uganda
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.00445784
|
0.00445784
|
0
|
0
|
0.00445784
|
0.00445784
|
0
|
0.00445784
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
DEVELOPING INNOVATIVE APPROACH...ES TO IMPROVE TREATMENT PROVISION FOR CHILDHOOD INFECTION IN PERI-URBAN SETTINGS: A PILOT STUDY IN ACCREDITED DRUG SHOPS
more
|
Developing innovative approach...es to improve treatment provision for childhood infection in peri-urban settings: A pilot study in accredited drug shops
more
|
MRC/WT/DfID/ESRC Joint Health ...System development award to look at ways to increase access to prompt effective treatment for childhood infections in peri-urban areas in Uganda
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
University, college or other t...eaching institution, research institute or think?tank
more
|
|
|
65678e1b212eaade2e0eb418
|
2017
|
United Kingdom
|
Department of Health
|
2017003947
|
16_137_109
|
1
|
China (People's Republic of)
|
Far East Asia
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
2.05622
|
0.0643832
|
0
|
0
|
2.05622
|
0.0643832
|
0
|
2.05622
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
NIHR GLOBAL HEALTH RESEARCH GR...OUP ON EVIDENCE TO POLICY PATHWAY TO IMMUNISATION IN CHINA (NIHR EPIC)
more
|
NIHR Global Health Research Gr...oup on Evidence to Policy Pathway to Immunisation in China (NIHR EPIC)
more
|
A UK and low- and middle-incom...e country (LMIC) partnership that aims to conduct applied vaccine research to help decision makers build a vaccination programme that ensures reliable, affordable, equitable and uninterrupted supply of vaccines to the poorest and most at-risk members of the population
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
University, college or other t...eaching institution, research institute or think?tank
more
|
|
|
65678e1c212eaade2e0eb419
|
2017
|
United Kingdom
|
Department of Health
|
2017003946
|
16_137_85
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
2.54839
|
0.0643832
|
0
|
0
|
2.54839
|
0.0643832
|
0
|
2.54839
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
NIHR GLOBAL HEALTH RESEARCH GR...OUP ON EARLY CHILDHOOD DEVELOPMENT FOR PEACEBUILDING
more
|
NIHR Global Health Research Gr...oup on Early Childhood Development for Peacebuilding
more
|
A UK and low- and middle-incom...e country (LMIC) partnership that aims to support the implementation and evaluation of early childhood development programmes and the potential to promote sustainable development and peacebuilding in LMICs affected by conflict
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
University, college or other t...eaching institution, research institute or think?tank
more
|
|
|
65678e1e212eaade2e0eb41a
|
2018
|
United Kingdom
|
Department of Health
|
2018003734
|
16_137_109
|
3
|
China (People's Republic of)
|
Far East Asia
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
4.62094
|
1.42271
|
0
|
0
|
4.62094
|
1.42271
|
0
|
4.62094
|
|
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
NIHR GLOBAL HEALTH RESEARCH GR...OUP ON EVIDENCE TO POLICY PATHWAY TO IMMUNISATION IN CHINA (NIHR EPIC)
more
|
NIHR Global Health Research Gr...oup on Evidence to Policy Pathway to Immunisation in China (NIHR EPIC)
more
|
A UK and low- and middle-incom...e country (LMIC) partnership that aims to conduct applied vaccine research to help decision makers build a vaccination programme that ensures reliable, affordable, equitable and uninterrupted supply of vaccines to the poorest and most at-risk members of the population
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
University, college or other t...eaching institution, research institute or think?tank
more
|
|
|
65678e1e212eaade2e0eb41b
|
2018
|
United Kingdom
|
Department for International D...evelopment
more
|
2018007126
|
200425-103
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.274007
|
0
|
0
|
0
|
0.274007
|
0
|
|
|
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
YOUNG LIVES PHASE 4: IMPROVED... POLICY DEBATE AND UNDERSTANDING OF THE CAUSES AND CONSEQUENCES OF CHILDHOOD POVETY AND INEQUALITY RESEARCH
more
|
Young Lives Phase 4: Improved... policy debate and understanding of the causes and consequences of childhood povety and inequality research
more
|
Improved policy debate and und...erstanding of the causes and consequences of childhood povety and inequality in the study countries and globally deriving from Young Lives evidence base.
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
University, college or other t...eaching institution, research institute or think?tank
more
|
|
|